Advisor Group Inc. boosted its holdings in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 18.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,194 shares of the real estate investment trust’s stock after acquiring an additional 14,261 shares during the period. Advisor Group Inc.’s holdings in Medical Properties Trust were worth $1,726,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of the business. Oakbrook Investments LLC boosted its stake in Medical Properties Trust by 3.0% during the 1st quarter. Oakbrook Investments LLC now owns 20,400 shares of the real estate investment trust’s stock worth $378,000 after purchasing an additional 600 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its holdings in Medical Properties Trust by 21.4% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 3,435 shares of the real estate investment trust’s stock valued at $55,000 after buying an additional 606 shares during the period. Oliver Luxxe Assets LLC raised its holdings in Medical Properties Trust by 4.2% in the 1st quarter. Oliver Luxxe Assets LLC now owns 16,456 shares of the real estate investment trust’s stock valued at $305,000 after buying an additional 656 shares during the period. Parallel Advisors LLC raised its holdings in Medical Properties Trust by 22.0% in the 4th quarter. Parallel Advisors LLC now owns 3,759 shares of the real estate investment trust’s stock valued at $60,000 after buying an additional 679 shares during the period. Finally, World Asset Management Inc raised its holdings in Medical Properties Trust by 4.3% in the 1st quarter. World Asset Management Inc now owns 17,774 shares of the real estate investment trust’s stock valued at $329,000 after buying an additional 734 shares during the period. Institutional investors own 80.64% of the company’s stock.
In other Medical Properties Trust news, Director Michael G. Stewart sold 6,830 shares of the firm’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $18.47, for a total value of $126,150.10. Following the sale, the director now directly owns 224,615 shares of the company’s stock, valued at approximately $4,148,639.05. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.18% of the stock is owned by company insiders.
Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, May 2nd. The real estate investment trust reported $0.31 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.01). Medical Properties Trust had a return on equity of 7.98% and a net margin of 131.84%. The firm had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $182.00 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The firm’s quarterly revenue was down 12.0% on a year-over-year basis. As a group, research analysts predict that Medical Properties Trust, Inc. will post 1.35 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, June 13th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.73%. The ex-dividend date of this dividend is Wednesday, June 12th. Medical Properties Trust’s dividend payout ratio is currently 72.99%.
Several analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Wednesday, April 17th. Deutsche Bank boosted their price objective on shares of Medical Properties Trust from $14.00 to $16.00 and gave the company a “hold” rating in a report on Friday, March 29th. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $17.79.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Article: What does RSI mean?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.